0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Repurposing Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-23J5563
Home | Market Reports | Health| Nursing
Global Drug Repurposing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drug Repurposing Market Research Report 2024

Code: QYRE-Auto-23J5563
Report
April 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Repurposing Market Size

The global Drug Repurposing market was valued at US$ 24570 million in 2023 and is anticipated to reach US$ 30920 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Drug Repurposing Market

Drug Repurposing Market

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Repurposing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing.

Report Scope

The Drug Repurposing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Repurposing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repurposing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Repurposing Market Report

Report Metric Details
Report Name Drug Repurposing Market
Accounted market size in 2023 US$ 24570 million
Forecasted market size in 2030 US$ 30920 million
CAGR 2.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oncology
  • CNS Diseases
  • Neurodegenerative Diseases
  • Others
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, NuMedii
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Repurposing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Repurposing Market growing?

Ans: The Drug Repurposing Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Drug Repurposing Market size in 2030?

Ans: The Drug Repurposing Market size in 2030 will be US$ 30920 million.

Who are the main players in the Drug Repurposing Market report?

Ans: The main players in the Drug Repurposing Market are Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, NuMedii

What are the Application segmentation covered in the Drug Repurposing Market report?

Ans: The Applications covered in the Drug Repurposing Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Drug Repurposing Market report?

Ans: The Types covered in the Drug Repurposing Market report are Oncology, CNS Diseases, Neurodegenerative Diseases, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 CNS Diseases
1.2.4 Neurodegenerative Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2019-2030)
2.2 Drug Repurposing Growth Trends by Region
2.2.1 Global Drug Repurposing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Repurposing Historic Market Size by Region (2019-2024)
2.2.3 Drug Repurposing Forecasted Market Size by Region (2025-2030)
2.3 Drug Repurposing Market Dynamics
2.3.1 Drug Repurposing Industry Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2019-2024)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2019-2024)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2023
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2019-2024)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2025-2030)
5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2019-2024)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Repurposing Market Size (2019-2030)
6.2 North America Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Repurposing Market Size by Country (2019-2024)
6.4 North America Drug Repurposing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repurposing Market Size (2019-2030)
7.2 Europe Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Repurposing Market Size by Country (2019-2024)
7.4 Europe Drug Repurposing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2019-2030)
8.2 Asia-Pacific Drug Repurposing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Repurposing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Repurposing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repurposing Market Size (2019-2030)
9.2 Latin America Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Repurposing Market Size by Country (2019-2024)
9.4 Latin America Drug Repurposing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2019-2030)
10.2 Middle East & Africa Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Repurposing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Repurposing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Drug Repurposing Introduction
11.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2019-2024)
11.1.5 Astellas Pharma Recent Development
11.2 Biovista
11.2.1 Biovista Company Detail
11.2.2 Biovista Business Overview
11.2.3 Biovista Drug Repurposing Introduction
11.2.4 Biovista Revenue in Drug Repurposing Business (2019-2024)
11.2.5 Biovista Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug Repurposing Introduction
11.3.4 Novartis Revenue in Drug Repurposing Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Drug Repurposing Introduction
11.4.4 AbbVie Revenue in Drug Repurposing Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repurposing Introduction
11.5.4 Pfizer Revenue in Drug Repurposing Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Drug Repurposing Introduction
11.6.4 Allergan Revenue in Drug Repurposing Business (2019-2024)
11.6.5 Allergan Recent Development
11.7 NuMedii
11.7.1 NuMedii Company Detail
11.7.2 NuMedii Business Overview
11.7.3 NuMedii Drug Repurposing Introduction
11.7.4 NuMedii Revenue in Drug Repurposing Business (2019-2024)
11.7.5 NuMedii Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Oncology
    Table 3. Key Players of CNS Diseases
    Table 4. Key Players of Neurodegenerative Diseases
    Table 5. Key Players of Others
    Table 6. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Drug Repurposing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Drug Repurposing Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Drug Repurposing Market Share by Region (2019-2024)
    Table 10. Global Drug Repurposing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Drug Repurposing Market Share by Region (2025-2030)
    Table 12. Drug Repurposing Market Trends
    Table 13. Drug Repurposing Market Drivers
    Table 14. Drug Repurposing Market Challenges
    Table 15. Drug Repurposing Market Restraints
    Table 16. Global Drug Repurposing Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Drug Repurposing Market Share by Players (2019-2024)
    Table 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2023)
    Table 19. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Drug Repurposing Product Solution and Service
    Table 23. Date of Enter into Drug Repurposing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Drug Repurposing Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Drug Repurposing Revenue Market Share by Type (2019-2024)
    Table 27. Global Drug Repurposing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Drug Repurposing Revenue Market Share by Type (2025-2030)
    Table 29. Global Drug Repurposing Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Drug Repurposing Revenue Market Share by Application (2019-2024)
    Table 31. Global Drug Repurposing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Drug Repurposing Revenue Market Share by Application (2025-2030)
    Table 33. North America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Drug Repurposing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Drug Repurposing Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Drug Repurposing Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Astellas Pharma Company Detail
    Table 49. Astellas Pharma Business Overview
    Table 50. Astellas Pharma Drug Repurposing Product
    Table 51. Astellas Pharma Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 52. Astellas Pharma Recent Development
    Table 53. Biovista Company Detail
    Table 54. Biovista Business Overview
    Table 55. Biovista Drug Repurposing Product
    Table 56. Biovista Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 57. Biovista Recent Development
    Table 58. Novartis Company Detail
    Table 59. Novartis Business Overview
    Table 60. Novartis Drug Repurposing Product
    Table 61. Novartis Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 62. Novartis Recent Development
    Table 63. AbbVie Company Detail
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Drug Repurposing Product
    Table 66. AbbVie Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 67. AbbVie Recent Development
    Table 68. Pfizer Company Detail
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Drug Repurposing Product
    Table 71. Pfizer Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 72. Pfizer Recent Development
    Table 73. Allergan Company Detail
    Table 74. Allergan Business Overview
    Table 75. Allergan Drug Repurposing Product
    Table 76. Allergan Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 77. Allergan Recent Development
    Table 78. NuMedii Company Detail
    Table 79. NuMedii Business Overview
    Table 80. NuMedii Drug Repurposing Product
    Table 81. NuMedii Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
    Table 82. NuMedii Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Repurposing Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Drug Repurposing Market Share by Type: 2023 VS 2030
    Figure 3. Oncology Features
    Figure 4. CNS Diseases Features
    Figure 5. Neurodegenerative Diseases Features
    Figure 6. Others Features
    Figure 7. Global Drug Repurposing Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Drug Repurposing Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Others Case Studies
    Figure 12. Drug Repurposing Report Years Considered
    Figure 13. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Drug Repurposing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Drug Repurposing Market Share by Region: 2023 VS 2030
    Figure 16. Global Drug Repurposing Market Share by Players in 2023
    Figure 17. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2023
    Figure 19. North America Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Drug Repurposing Market Share by Country (2019-2030)
    Figure 21. United States Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Drug Repurposing Market Share by Country (2019-2030)
    Figure 25. Germany Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Drug Repurposing Market Share by Region (2019-2030)
    Figure 33. China Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Drug Repurposing Market Share by Country (2019-2030)
    Figure 41. Mexico Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Drug Repurposing Market Share by Country (2019-2030)
    Figure 45. Turkey Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Astellas Pharma Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 48. Biovista Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 49. Novartis Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 50. AbbVie Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 51. Pfizer Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 52. Allergan Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 53. NuMedii Revenue Growth Rate in Drug Repurposing Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS